Abstract:OBJECTIVE:To explore the association between serum inflammation levels and cognitive function in patients with obstructive sleep apnea-hypopnea syndromes (OSAHS) and evaluate the effects of continuous positive airway pressure treatment (CPAP) on serum inflammation levels and cognitive function. METHODS:A total of 139 eligible patients were monitored by overnight polysomnography (PSG) at Sleep Center, Second Affiliated Hospital, Soochow University from June 2011 to April 2013. Based on the results of apnea-hypopnea index (AHI), they were divided into 4 groups of primary snoring (n = 18), mild OSAHS(n = 23), moderate OSAHS (n = 29) and severe OSAHS (n = 69). The questionnaires of Montreal Cognitive Assessment (MoCA), Mini-Mental State Examination (MMSE) and Epworth Sleepiness Scale (ESS) were administered to assess cognitive function and daytime sleepiness. The serum levels of high-sensitivity C-reactive protein (Hs-CRP), leptin and tumor necrosis factor alpha (TNF-α) were detected to evaluate systemic inflammation. The questionnaire scores, serum levels of Hs-CRP, leptin and TNF-α and PSG parameters were compared among 4 groups. Thirty-three patients in severe OSAHS group (treatment group) with good adherence were evaluated at baseline and after long-time CPAP treatment. RESULTS:Compared to primary snoring group, the serum Hs-CRP ((1.77 ± 1.19) vs (0.92 ± 0.82) mg/L), leptin ((15.21 ± 13.26) vs (6.35 ± 4.51) mmol/L) and TNF-α ((21.04 ± 7.78) vs (10.30 ± 5.23) pmol/L) levels increased significantly in severe OSAHS group (P < 0.05). After adjusting for body mass index (BMI), age and education years, MoCA scores showed negative correlations with serum TNF-α, AHI, oxygen reduction index (ODI) and TS90% (r = -0.266, -0.236, -0.201, -0.18 respectively, all P < 0.05) and positive correlations with minimum oxygen saturation (LSaO(2)) (r = 0.224, P < 0.05). The evaluations of MoCA subdomains further revealed selective reductions in visual space, executive function, attention and delayed memory function. The treatment group with good adherence to > 6-month continuous positive airway pressure (CPAP) treatment and after CPAP treatment, the serum levels of Hs-CRP, TNF-α and leptin improved markedly ((1.20 ± 0.88) vs (2.03 ± 1.58) mg/L, (14.12 ± 4.34) vs (22.74 ± 6.72) pmol/L and (7.37 ± 5.30) vs (13.69 ± 7.17) mmol/L respectively). The scores of MoCA and ESS also improved (27.79 ± 1.69 vs 24.76 ± 2.57, 4.33 ± 3.14 vs 12.61 ± 5.80 respectively) (all P < 0.01). The score of all MoCA subdomains improved after treatment. CONCLUSIONS:Cognitive dysfunction and inflammatory reaction are common in OSAHS patients. MoCA scores are correlated significantly with serum level of TNF-α and nocturnal intermittent hypoxia. Systemic inflammation may play an important role in cognitive dysfunction of OSAHS patients. And long-time CPAP treatment can improve systemic inflammatory response and cognitive impairment.

Effect of continuous positive airway pressure on blood ICAM-1 in obstructive sleep apnea syndrome patients

Effects of Continuous Positive Airway Pressure on Adhesion Molecules and P-selectin in Coronary Heart Disease Patients with Obstructive Sleep Apnea Syndrome

Effects of Continuous Positive Airway Pressure on C-reactive Protein and Interleukin-6 in Obstructive Sleep Apnea-hypopnea Syndrome with Hypertension

Influence of Continuous Positive Airway Pressure Treatment on Cardiovascular Risk Factors in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Effects of Continuous Positive Airway Pressure on Serum Inflammatory Factors in Coronary Heart Disease Patients Complicated with Obstructive Sleep Apnea-Hypopnea Syndrome

Constant positive airway pressure treated coronary heart disease with obstructive sleep apnea syndrome and changed levels of intercellular adhesion molecules

Effect of continuous positive airway pressure therapy on blood pressure variability of obstructive sleep apnea hypopnea syndrome

[Impact of Long-Term Continuous Positive Airway Pressure Treatment for Patients with Obstructive Sleep Apnea Syndrome].

Obstructive sleep apnea syndrome treated by continous positive airway pressure

Changes and significances of serum interleukin-8 and monocyte chemoattractant protein-1 levels in patients with obstructive sleep apnea syndrome

Effects of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnea Hypopnea Syndrome

Nasal continuous positive airway pressure treat obstructive sleep apnea syndrome

Effects of short-term treatment of Continuous positive airway pressure on the Cognitive disorder,Serum Insulin-Like Growth Factor-1 in Patients With Obstructive Sleep Apnea hypopnea Syndrome

[Association between inflammation and cognitive function and effects of continuous positive airway pressure treatment in obstructive sleep apnea hypopnea syndrome].

[Effects of Continuous Positive Airway Pressure on Daytime Sleepiness in Patients with Severe Obstructive Sleep Apnea Syndrome].

Survey on the compliance of the continuous positive airway pressure in obstructive sleep apnea hypopnea syndrome

Changes in Plasma Interleukin-18 and Monocyte Chemotaxis Protein-1 in Obstructive Sleep Apnea Syndrome and Their Significance

Improvement on Inflammation and Insulin Resistance after Continuous Positive Airway Pressure in Patients with Type 2 Diabetes Mellitus and Obstructive Sleep Apnea Hypopnea Syndrome

Effect of Continuous Positive Airway Pressure on Lipid Profile in Patients with Obstructive Sleep Apnea Syndrome: a Meta-Analysis of Randomized Controlled Trials.

Perioperative Continuous Positive Airway Pressure Treatment for Obstructive Sleep Apnea Hypopnea Syndrome

[Efficacy of Simple Continuous Positive Airway Pressure on Patients with Obstructive Sleep Apnea].